GSK Pharmaceuticals India focuses on affordable general medicine access amidst premiumisation trend, discussed by managing ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

Though prescribing climate-friendly dry powder inhalers is environmentally sound, some experts warn certain patients may be ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

While generics may dominate due to cost advantages and meeting needs of a developing economy, there is a growing thrust ...

DelveInsight's 'Severe Asthma Pipeline Insight 2024' report provides comprehensive global coverage of pipeline severe asthma ...

There’s no better time to be alive, only if we can learn to thrive amidst constant change and disruption” muses health tech ...

the full trial data paints a more down-to-earth reality – with some disappointing real-world outcomes for GSK. Data published by the New England Journal of Medicine (NEJM) on Sunday shows the ...

It would be unhealthy to let Robert F. Kennedy Jr. take charge of U.S. physical well-being. President-elect Donald Trump said on the campaign trail that he wants the anti-vaccine activist to “run wild ...

Net financial result for the three and nine months ended September 30, 2024, amounted to €2.2 million and €8.0 million, or a decrease of €3.1 million and €4.7 million, from €5.3 million and €12.7 ...

GSK's new long-acting drug candidate for severe ... The data was published in the New England Journal of Medicine at the same time as being presented at ERS. If approved, depemokimab would be ...